Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewsWire • 09/14/20
Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment ConferenceGlobeNewsWire • 09/10/20
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only MeetingGlobeNewsWire • 08/27/20
Zomedica Adds Two New Directors To Board Annual Meeting Materials AvailabilityGlobeNewsWire • 08/07/20
Zomedica Pharmaceuticals Corp. (ZOM) Gains But Lags Market: What You Should KnowZacks Investment Research • 08/03/20
Zomedica Pharmaceuticals Corp. (ZOM) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 07/27/20
Zomedica Pharmaceuticals Corp. (ZOM) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 07/17/20
Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product LaunchGlobeNewsWire • 06/16/20
Zomedica Completes Verification of Three More Assays for its TRUFORMA™ Point-of-Care Diagnostic PlatformGlobeNewsWire • 05/20/20
Zomedica Pharmaceuticals Corp (ZOM) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/11/20
Zomedica Completes Verification of its TRUFORMA™ Point-of-Care Diagnostic Platform and the First Assay, Canine total T4GlobeNewsWire • 04/21/20
Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public OfferingGlobeNewsWire • 04/08/20